Adapting Single Sessions Interventions for Type 1 Diabetes

计划入组 80 人 · 首次发布于 2024 年 12 月 30 日

FAMS-T1D Self-Regulation and Social Support for T1D

计划入组 280 人 · 首次发布于 2023 年 4 月 19 日

Adolescent Interventions to Manage Self-regulation of T1D (AIMS T1D)

计划入组 88 人 · 首次发布于 2018 年 9 月 28 日

T1D-ADV210

T1D-PT101

RTX-T1D

Autoimmune Technologies, LLC

United States

Genmab A/S

Denmark

Bristol-Myers Squibb Company

United States

SAB BIO Secures $175 Million Funding to Advance Type 1 Diabetes Immunotherapy Through Phase 2b Trial

Greenstone Biosciences Awarded Breakthrough T1D Grant to Build a T1D-Derived Islet Cell Platform

Integrated Nanotherapeutics Receives Grant to Advance Type 1 Diabetes Immunotherapy